Vitamin D and vitamin D analogs as cancer chemopreventive agents

Kathryn Z. Guyton, Thomas W Kensler, Gary H. Posner

Research output: Contribution to journalArticle

Abstract

Epidemiologic studies have associated vitamin D, attained through nutrition and sun exposure, with reduced cancer risk. Although dose-limiting hypercalcemia has limited the use of natural vitamin D in cancer prevention, several promising new synthetic vitamin D analogs (deltanoids) are under development. Examples are KH-1060, EB-1089, 1 α-hydroxyvitamin D 5, vitamin D2, and QW-1624F2-2. Clinical targets for deltanoids include colon, prostate, and breast. Studies to elucidate the molecular mechanisms underlying the observed efficacy of deltanoids are ongoing. The vitamin D receptor, a steroid/thyroid receptor superfamily member, appears to control most deltanoid effects on proliferation, apoptosis, differentiation, and angiogenesis.

Original languageEnglish (US)
Pages (from-to)227-238
Number of pages12
JournalNutrition Reviews
Volume61
Issue number7
DOIs
StatePublished - Jul 1 2003

Fingerprint

vitamin D
Vitamin D
neoplasms
Ergocalciferols
Neoplasms
Calcitriol Receptors
Hydroxycholecalciferols
Steroid Receptors
Hypercalcemia
Solar System
ergocalciferol
hypercalcemia
Epidemiologic Studies
Prostate
Thyroid Gland
Colon
Breast
angiogenesis
epidemiological studies
Apoptosis

Keywords

  • 25-dihydroxyvitamin D analogs
  • Calcitriol analogs
  • Deltanoids

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Food Science

Cite this

Vitamin D and vitamin D analogs as cancer chemopreventive agents. / Guyton, Kathryn Z.; Kensler, Thomas W; Posner, Gary H.

In: Nutrition Reviews, Vol. 61, No. 7, 01.07.2003, p. 227-238.

Research output: Contribution to journalArticle

Guyton, Kathryn Z. ; Kensler, Thomas W ; Posner, Gary H. / Vitamin D and vitamin D analogs as cancer chemopreventive agents. In: Nutrition Reviews. 2003 ; Vol. 61, No. 7. pp. 227-238.
@article{1345689c88ca489eb7d0f9d8404c4445,
title = "Vitamin D and vitamin D analogs as cancer chemopreventive agents",
abstract = "Epidemiologic studies have associated vitamin D, attained through nutrition and sun exposure, with reduced cancer risk. Although dose-limiting hypercalcemia has limited the use of natural vitamin D in cancer prevention, several promising new synthetic vitamin D analogs (deltanoids) are under development. Examples are KH-1060, EB-1089, 1 α-hydroxyvitamin D 5, vitamin D2, and QW-1624F2-2. Clinical targets for deltanoids include colon, prostate, and breast. Studies to elucidate the molecular mechanisms underlying the observed efficacy of deltanoids are ongoing. The vitamin D receptor, a steroid/thyroid receptor superfamily member, appears to control most deltanoid effects on proliferation, apoptosis, differentiation, and angiogenesis.",
keywords = "1α, 25-dihydroxyvitamin D analogs, Calcitriol analogs, Deltanoids",
author = "Guyton, {Kathryn Z.} and Kensler, {Thomas W} and Posner, {Gary H.}",
year = "2003",
month = "7",
day = "1",
doi = "10.1301/nr.2003.jul.227-238",
language = "English (US)",
volume = "61",
pages = "227--238",
journal = "Nutrition Reviews",
issn = "0029-6643",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - Vitamin D and vitamin D analogs as cancer chemopreventive agents

AU - Guyton, Kathryn Z.

AU - Kensler, Thomas W

AU - Posner, Gary H.

PY - 2003/7/1

Y1 - 2003/7/1

N2 - Epidemiologic studies have associated vitamin D, attained through nutrition and sun exposure, with reduced cancer risk. Although dose-limiting hypercalcemia has limited the use of natural vitamin D in cancer prevention, several promising new synthetic vitamin D analogs (deltanoids) are under development. Examples are KH-1060, EB-1089, 1 α-hydroxyvitamin D 5, vitamin D2, and QW-1624F2-2. Clinical targets for deltanoids include colon, prostate, and breast. Studies to elucidate the molecular mechanisms underlying the observed efficacy of deltanoids are ongoing. The vitamin D receptor, a steroid/thyroid receptor superfamily member, appears to control most deltanoid effects on proliferation, apoptosis, differentiation, and angiogenesis.

AB - Epidemiologic studies have associated vitamin D, attained through nutrition and sun exposure, with reduced cancer risk. Although dose-limiting hypercalcemia has limited the use of natural vitamin D in cancer prevention, several promising new synthetic vitamin D analogs (deltanoids) are under development. Examples are KH-1060, EB-1089, 1 α-hydroxyvitamin D 5, vitamin D2, and QW-1624F2-2. Clinical targets for deltanoids include colon, prostate, and breast. Studies to elucidate the molecular mechanisms underlying the observed efficacy of deltanoids are ongoing. The vitamin D receptor, a steroid/thyroid receptor superfamily member, appears to control most deltanoid effects on proliferation, apoptosis, differentiation, and angiogenesis.

KW - 1α

KW - 25-dihydroxyvitamin D analogs

KW - Calcitriol analogs

KW - Deltanoids

UR - http://www.scopus.com/inward/record.url?scp=0041734672&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041734672&partnerID=8YFLogxK

U2 - 10.1301/nr.2003.jul.227-238

DO - 10.1301/nr.2003.jul.227-238

M3 - Article

C2 - 12918875

AN - SCOPUS:0041734672

VL - 61

SP - 227

EP - 238

JO - Nutrition Reviews

JF - Nutrition Reviews

SN - 0029-6643

IS - 7

ER -